Brain angiotensin and circulatory control

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 6-7, 1996, Pages 458-464

  Muratani, Hiromi ^a,b   Teruya, Hiroshi ^a   Sesoko, Shogo ^a   Takishita, Shuichi ^a   Fukiyama, Koshiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NONE   (Japan)

Author keywords

angiotensin II; blood pressure; brainstem; circumventricular organs; hypertension; hypothalamus; sympathetic activity; vasopressin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR;

ADRENERGIC STIMULATION; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN STEM; HYPERTENSION; PREOPTIC NUCLEUS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY; SODIUM METABOLISM; SOLITARY TRACT NUCLEUS; THALAMUS MIDLINE NUCLEUS;

EID: 0029948168     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02761.x     Document Type: Short Survey

References (99)

1. Weindl A. Neuroendocrine aspects of circumventricular organs. In: Ganong WF, Martini L (eds). Frontiers in Neuroendocrinology, 1973. Oxford University Press, New York. 1973; Ch. 1.
2. Bickerton RK, Buckley JP. Evidence for a central mechanism of angiotensin induced hypertension. Proc. Soc. Exp. Biol. Med. 1961; 106: 834-7.
3. Allen AM, Paxinos G, Song KF, Mendelsohn FAO. Localization of angiotensin receptor bindings sites in the rat brain. In: Björklund A, Hökfelt T, Kuhar MJ (eds). Handbook of Chemical Neuroanatomy, Vol. 1. Elsevier, Amsterdam. 1992; Ch. 1.
4. Saavedra JM. Brain and pituitary angiotensin. Endocrinol. Rev. 1992; 13: 329-80.
5. Wright JW, Harding JW. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res. Rev. 1992; 17: 227-62.
6. Timmermans PBMWM, Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmocol. Revu. 1993; 45: 205-51.
7. Epstein AN, Fitzsimons JT, Rolls BJ. Drinking induced by injection of angiotensin into the brain of the rat. J Physiol. 1970; 210: 457-74.
8. Buggy J, Fisher AE. Evidence for a dual central role for angiotensin in water and sodium intake. Nature 1974; 250: 733-5.
9. Nashold BS Jr, Mannarino E, Wunderlich M. Pressor-depressor blood pressure responses in the cat after intraventricular injection of drugs. Nature 1962; 193: 1297-8.
10. Anderson B, Westbye O. Synergistic action of sodium and angiotensin on brain mechanisms controlling fluid balance. Life Sci. 1970; 9: 601-8.
11. Keil LC, Summy-Long J, Severs WB. Release of vasopressin by angiotensin II. Endocrinology 1975; 96: 1063-5.
12. Fitzsimons JT, Kucharczyk J. Drinking and haemodynamic changes induced in the dog by intracranial injection of components of the renin-angiotensin system. J. Physiol. 1978; 276: 419-34.
13. Fink GD, Bryan WJ. Forebrain control of fluid and electrolyte homeostasis and angiotensin sensitivity in rabbit. Am. J. Physiol. 1980; 239: R372-6.
14. Wright JW, Sullivan MJ, Peterson EP, Harding JW. Brain angiotensin II and III binding and dipsogenicity in the rabbit. Brain Res. 1985; 358: 376-9.
15. Head GA, Williams NS. Hemodynamic effects of central angiotensin I, II, and III in conscious rabbits. Am. J. Physiol. 1992; 263: R845-51.
16. Mangiapane ML, Simpson JB. Subfornical organ: Forebrain site of pressor and dipsogenic action of angiotensin II. Am. J. Physiol. 1980; 239: R382-9.
17. Brody MJ, Johnson AK. Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation, and hypertension. In: Martini I, Ganong WF (eds). Frontiers in Neuroendocrinology, vol. 6. Raven Press, New York. 1980; Ch. 9.
18. Mendelsohn FA, Qurion R, Saavedra JM, Aguilera G, Catt KJ. Autoradiographic localization of angiotensin II receptors in rat brain. Proc. Natl Acad. Sci. USA 1984; 81: 1575-9.
19. Simpson JB, Routtenberg A. Subfornical organ: Site of drinking elicitation by angiotensin II. Science 1973; 181: 1172-5.
20. Phillips MI. Angiotensin in the brain. Neuroendocrinology 1978; 25: 354-77.
21. McKinley MJ, Badoer E, Vivas I., Oldfield BJ. Comparison of c-fos expression in the lamina terminalis of conscious rats after intravenous or intracerebroventricular angiotensin. Brain Res. Bull. 1995; 37: 131-7.
22. Buggy J, Fisher AE, Hoffman WE, Johnson AK, Phillips MI. Ventricular obstruction: Effect on drinking induced by intracranial injection of angiotensin. Science 1975; 190: 72-4.
23. Weindl A, Joynt RJ. The median eminence as a circumventricular organ. In: Knigge KM, Scott DE, Weindl A (eds). Brain-Endocrine Interaction. Median Eminence: Structure and Function. International Symposium, Munich 1971. Karger, Basel. 1972; 280-97.
24. Phillips MI, Stamler JF, Raizada NK. Visualization of specific angiotensin II binding sites in the brain by fluorescent microscopy. Science 1980; 210: 791-3.
25. 125I] angiotensin II to the circumventricular organs. Neuroscience 1983; 10: 1421-6.
26. Simpson JB, Routtenberg A. Subfornical organ lesions reduce intravenous angiotensin-induced drinking. Brain Res. 1975; 88: 154-61.
27. Buggy J, Johnson AK. Preoptic-hypothalamic periventricular lesions: Thirst deficits and hypernatremia. Am. J. Physiol. 1977; 233: R44-52.
28. Rowland NE, Li B-H, Rozelle AK, Fregly JJ, Garcia M, Smith GC. Localization of changes in immediate early genes in brain in relation to hydromineral balance: Intravenous angiotensin II. Brain Res. Bull. 1994; 33: 427-36.
29. Miselis RR, Shapiro RE, Hand PJ. Subfornical organ efferents to neural systems for control of body water. Science 1979; 205: 1022-5.
30. Lind RW, Swanson LW, Bruhn TO, Ganten D. Angiotensin II immunoreactivity in the neural afferents and efferents of the subfornical organ of the rat. Brain Res. 1984; 321: 209-15.
31. Tanaka J, Saito H, Seto K. The median preoptic nucleus participates in the control of paraventricular vasopressin neurons by the subfornical organs in the rat. Brain Res. 1988; 461: 403-6.
32. Jones DL. Kainic acid lesions of the median preoptic nucleus: Effects on angiotensin II induced drinking and pressor response in the conscious rat. Can. J. Physiol. Pharmacol. 1988; 66: 1082-6.
33. Jhamandas JH, Lind RW, Renaud LP. Angiotensin II may mediate excitatory neurotransmission from the subfornical organ to the hypothalamic supraoptic nucleus: An anatomical and electrophysiological study in the rat. Brain Res. 1989; 487: 52-61.
34. Ferguson AV, Renaud LP. Hypothalamic paraventricular nucleus lesions decrease pressor responses to subfornical organ stimulation. Brain Res. 1984; 305: 361-4.
35. Jensen LL, Harding JW, Wright LW. Role of the paraventricular nucleus of the hypothalamus in the angiotensinergic control of blood pressure and drinking in the rat. Am. J. Physiol. 1992; 262: F1068-75.
36. Li Z, Ferguson AV. Subfornical organ efferents to paraventricular nucleus utilize angiotensin as a neurotransmitter. Am. J. Physiol. 1993; 265: R302-9.
37. Smookler HH, Severs WB, Kinnard WJ, Buckley JP. Centrally mediated cardiovascular effects of angiotensin II. J. Pharmacol. Exp. Ther. 1966; 153: 485-94.
38. Falcon JC Jr, Phillips MI, Hoffman WE, Brody MJ. Effects of intraventricular angiotensin II mediated by sympathetic nervous system. Am. J. Physiol. 1978; 235: H392-9.
39. Haack D, Möhring J. Vasopressin-mediated blood pressure response to intraventricular injection of angiotensin II in the rat. Pflügers Arch. 1978; 373: 167-73.
40. Unger T, Rascher W, Schuster C et al. Central blood pressure effects of substance P and angiotensin II: Role of the sympathetic nervous system and vasopressin. Eur. J. Pharmacol. 1981; 71: 33-42.
41. Yang R-H, Jin H, Wyss JM, Oparil S. Depressor effect of blocking angiotensin subtype I receptors in anterior hypothalamus. Hypertension 1992; 19: 475-81.
42. Unger T, Horst PJ, Bauer M, Demmert G, Rettig R, Rohmeiss P. Natriuretic action of angiotensin II in conscious rats. Brain Res. 1989; 486: 33-8.
43. Brooks VL, Malvin RL. Intracerebroventricular infusion of angiotensin II increases sodium excretion. Proc. Soc. Exp. Biol. 1982; 169: 532-7.
44. Fukiyama K. Central action of angiotensin and hypertension-induced central vasomotor outflow by angiotensin. Jpn. Circ. J. 1972; 36: 599-602.
45. Malvin RL, Mouw D, Vander AJ. Angiotensin: Physiological role in water-deprivation-induced thirst of rats. Science 1977; 197: 171-3.
46. DiNicolantonio R, Hutchinson JS, Mendelsohn FAO. Exaggerated salt appetite of spontaneously hypertensive rats is decreased by central angiotensin-converting enzyme blockade. Nature 1982; 298: 846-8.
47. Weiss ML, Moe KE, Epstein AN. Interference with central actions of angiotensin II suppresses sodium appetite. Am. J. Physiol. 1986; 350: R250-9.
48. Phillips MI, Mann JFE, Haebara H et al. Lowering of hypertension by central saralasin in the absence of plasma renin. Nature 1977; 270: 445-7.
49. 8 AII) in normotensive and spontaneously hypertensive rat strains. Brain Res. 1988; 448: 359-63.
50. McKinley MJ, Evered M, Mathai M, Coghlan JP. Effects of central losartan on plasma renin and centrally mediated natriuresis. Kidney Int. 1994; 46: 1479-82.
51. Brooks VL, Malvin RL. An intracerebral, physiological role for angiotensin: Effects of central blockade. Fed. Proc. 1979; 38: 2272-5.
52. Rohmeiss P, Demmert G, Unger T. Centrally administered atrial natriuretic factor inhibits central angiotensin induced natriuresis. Brain Res. 1989; 502: 198-203.
53. Imura H, Nakao K, Itoh H. The natriuretic peptide system in the brain: Implications in the cardiovascular and neuroendocrine functions. Front. Neuroendocrinol. 1992; 13: 217-49.
54. Mendelsohn FAO, Allen AM, Chai SY, Sexton PM, Figdor R. Overlapping distributions of receptors for atrial natriuretic peptide and angiotensin II visualized by in vitro autoradiography: morphological basis of physiological antagonism. Can. J. Physiol. Pharmacol. 1987; 65: 1517-21.
55. Bruhwyler J, Chleide E, Liegeois JF, Carreer F. Nitric oxide: A new messenger in the brain. Neurosci. Biobehav. Rev. 1993; 17: 378-84.
56. Calapai G, Squadrito F, Altavilla D et al. Evidence that nitric oxide modulates drinking behavior. Neuropharmacology 1992; 31: 761-4.
57. Bains JS, Ferguson AV. Angiotensin II neurotransmitter actions in paraventricular nucleus are potentiated by a nitric oxide synthase inhibitor. Regul. Pept. 1994; 50: 53-9.
58. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamo-neuro-hypophysial system by angiotensin (1-7) heptapeptide. Proc. Natl Acad. Sci. USA 1988; 85: 4095-8.
59. Elghozi J-L, Head GA. Spinal noradrenergic pathways and pressor responses to central angiotensin II. Am. J. Physiol. 1990; 258: H240-6.
60. Ueda H, Uchida Y, Ueda K, Gondaira T, Katayama S. Centrally mediated vasopressor effect of angiotensin II in man. Jpn Heart J. 1969; 10: 243-7.
61. Swanson LW, Sharpe LG. Centrally induced drinking: Comparison of angiotensin II- and carbachol-sensitive sites in rats. Am. J. Physiol. 1973; 225: 566-73.
62. Joy MD, Lowe RD. Evidence that the area postrema mediates the central cardiovascular response to angiotensin II. Nature 1970; 228: 1303-4.
63. Haywood JP, Fink GD, Buggy J, Phillips MI, Brody MJ. The area postrema plays no role in the pressor action of angiotensin in the rat. Am. J. Physiol. 1980; 239: H108-13.
64. Fink GD, Bruner C, Mangiapane ML. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension 1987; 9: 355-61.
65. Lowes VL, McLean LE, Kasting NW, Ferguson AW. Cardiovascular consequences of microinjection of vasopressin and angiotensin II in the area postrema. Am. J. Physiol. 1993; 265: R625-31.
66. Fukiyama K. Central modulation of baroreceptor reflex by angiotensin. Jpn. Heart J. 1973; 14: 135-9.
67. Kooy D, Koda LY. Organization of the projections of a circumventricular organ: The area postrema in the rat. J. Comp. Neurol. 1983; 219: 328-38.
68. Campagnole-Santos MJ, Diz DJ, Ferrario CM. Baroreceptor reflex modulation by angiotensin II at the nucleus tractus solitarii. Hypertension 1988; 11: 1167-71.
69. Casto R, Phillips MI. Mechanism of pressor effects by angiotensin in the nucleus tractus solitarius of rats. Am. J. Physiol. 1984; 247: R575-81.
70. Casto R, Phillips MI. Neuropeptide action in nucleus tractus solitarius: Angiotensin specificity and hypertensive rats. Am. J. Physiol. 1985; 249: R341-7.
71. Diz DI, Barnes KL, Ferrario CM. Hypotensive actions of microinjections of angiotensin II into the dorsal motor nucleus of the vagus. J. Hypertens. 1984; 2 (Suppl. 3): S53-6.
72. Averill DB, Diz DI, Barnes KL, Ferrario CM. Pressor responses of angiotensin II microinjected into the dorsomedial medulla of the dog. Brain Res. 1987; 414: 294-300.
73. Sun M, Young BS, Hackett JT, Guyenet PG. Reticulospinal pacemaker neurons of the rat rostral ventrolateral medulla with putative sympathoexcitatory function: An intracellular study in vitro. Brain Res. 1988; 442: 229-39.
74. Granata AN, Numao Y, Kumada M, Reis DJ. A1 noradrenergic neurons tonically inhibit sympathoexcitatory neurons of C1 area in rat brainstem. Brain Res. 1985; 377: 127-46.
75. Song K, Allen AM, Paxinos G, Mendelsohn FAO. Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J. Comp. Neurol. 1992; 316: 467-84.
76. Allen AM, Dampney RAL, Mendelsohn FAO. Angiotensin receptor binding and pressor effects in cat subretrofacial nucleus. Am. J. Physiol. 1988; 255: H1011-17.
77. Andreatta SH, Averill DB, Santos RAS, Ferrario CM. The ventrolateral medulla: A new site of action of the renin-angiotensin system. Hypertension 1988; 11: 1163-6.
78. Sasaki S, Dampney RAL. Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension 1990; 15: 274-83.
79. Muratani H, Averill DB, Ferrario CM. Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am. J. Physiol. 1991; 260: R977-84.
80. Allen AM, Mendelsohn FAO, Gieroba ZJ, Blessing WW. Vasopressin release following microinjection of angiotensin II into the caudal ventrolateral medulla oblongata in the anaesthetized rabbit. J. Neuroendocrinol. 1990; 2: 867-74.
81. Muratani H, Ferrario CM, Averill DB. Ventrolateral medulla in spontaneously hypertensive rats: Role of angiotensin II. Am. J. Physiol. 1993; 264: R388-95.
82. Li, Y-W, Guyenet PG. Neuronal excitation by angiotensin II in the rostral ventrolateral medulla of the rat in vitro. Am. J. Physiol. 1995; 268: R272-7.
83. Cravo SL, Morrison SF, Reis DJ. Differentiation of two cardiovascular regions within caudal ventrolateral medulla. Am. J. Physiol. 1991; 261: R985-94.
84. Sesoko S, Muratani H, Takishita S, Teruya H, Kawazoe N, Fukiyama K. Modulation of baroreflex function by angiotensin II endogenous to the caudal ventrolateral medulla. Brain Res. 1995; 671: 38-44.
85. Dorward PK, Rudd CD. Influence of brain renin-angiotensin system on renal sympathetic and cardiac baroreflex in conscious rabbits. Am. J. Physiol. 1990; 260: H770-8.
86. Harris MC, Loewy AD. Neural regulation of vasopressin-containing hypothalamic neurons and the role of vasopressin in cardiovascular function. In: Loewy AD, Spyer KM (eds). Central Regulation of Autonomie Functions. Oxford, New York. 1990; Ch. 13.
87. Fukiyama K, McCubbin JW, Page IH. Chronic hypertension elicited by infusion of angiotensin into vertebral arteries of unanesthetized dogs. Clin. Sci. 1971; 40: 283-91.
88. Otsuka A, Barnes KL, Ferrario CM. Contribution of area postrema to pressor actions of angiotensin II in dog. Am. J. Physiol. 1986; 251: H538-46.
89. Fink GD, Bryan WJ, Mokler DJ. Effects of chronic intracerebroventricular infusion of angiotensin II on arterial pressure and fluid homeostasis. Hypertension 1982; 4: 312-19.
90. Bruner CA, Fink GD. Neurohumoral contributions to chronic angiotensin-induced hypertension. Am. J. Physiol. 1986; 250: H52-61.
91. Ganten D, Hermann K, Bayer C, Unger T, Lange RE. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science 1983; 221: 869-71.
92. Saavedra JM, Correa FMA, Plunkett LM, Israel A, Kurihara M, Shigematsu K. Binding of angiotensin and atrial natriuretic peptide in brain of hypertensive rats. Nature 1986; 320: 758-60.
93. McDonald WJM, Wickre C, Aumann SK, Ban D, Moffitt B. The sustained antihypertensive effect of chronic cerebroventricular infusion of angiotensin antagonist in spontaneously hypertensive rats. Endocrinology 1980; 107: 1305-8.
94. Okuno T, Nagahama S, Lindheimer MD, Oparil S. Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril. Hypertension 1983; 5: 653-62.
95. Buckley JP, Lokhandwala MF, Steenberg MS, Francis JS, Tadepali AS. Cardiovascular effects of chronic intraventricular administration of angiotensin II in dogs. Clin. Exp. Hypertens. 1981; 3: 1001-18.
96. Bruner CA, Weaver JM, Fink GD. Sodium-dependent hypertension by chronic central angiotensin II infusion. Am. J. Physiol. 1985; 249: H321-7.
97. Takata Y, Yamashita Y, Takishita S, Kimura Y, Fujishima M. Brain renin angiotensin system contributes to the salt-induced enhancement of hypertension in SHR. Clin. Exp. Hypertens. 1986; A8: 1149-70.
98. Haya Y, Suzuki H, Matsukawa S, Kondo K, Saruta T. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. Am. J. Physiol. 1986; 251: H261-8.
99. Teruya H, Muratani H, Takishita S, Sesoko S, Matayoshi R, Fukiyama K. Brain angiotensin II contributes to the development of hypertension in Dahl-Iwai salt-sensitive rats. J. Hypertens. 1995; 13: 883-90.